Clinical Trial of CG-BM1 Allogeneic Human Bone Marrow Mesenchymal Stem Cell Injection in the Treatment of Sarcopenia

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
1. To evaluate the safety and tolerability of CG-BM1 for the treatment of patients with Sarcopenia. 2. To observe the preliminary effectiveness of CG-BM1 in treating Sarcopenia patients.
Epistemonikos ID: c5a9825639eca1514763089c8b2220313a0c215c
First added on: Oct 09, 2026